Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-hydroxyethylurea
2. 2078-71-9
3. 1-(2-hydroxyethyl)urea
4. (2-hydroxyethyl)urea
5. Monoethanolurea
6. Monoethylolurea
7. Hydroxyethyl Urea
8. 1-ethanolurea
9. 1320-51-0
10. Urea, N-(hydroxyethyl)-
11. Hydroxyethylurea
12. (hydroxyethyl)urea
13. N-(2-hydroxyethyl)urea
14. Urea, (hydroxyethyl)-
15. N-(hydroxyethyl)-urea
16. Mbq7ddq7ar
17. N-(.beta.-hydroxyethyl)urea
18. Nsc-1127
19. Mfcd00059080
20. (beta-hydroxyethyl)urea
21. N-(beta-hydroxyethyl)urea
22. Unii-mbq7ddq7ar
23. Nsc 1127
24. Brn 1098722
25. Nsc1127
26. Einecs 215-304-0
27. 2-hydroxyethyl Urea
28. N-2-hydroxyethylurea
29. Hydrovance
30. (2-hydroxy-ethyl)-urea
31. (.beta.-hydroxyethyl)urea
32. Ec 215-304-0
33. Schembl27663
34. 4-04-00-01545 (beilstein Handbook Reference)
35. (2-hydroxyethyl)urea, 95%
36. (2-hydroxy Ethyl)urea
37. Hydroxyethyl Urea [inci]
38. Schembl17075248
39. Clahozsymrnipy-uhfffaoysa-
40. Dtxsid401315038
41. Hydroxyethyl Urea [who-dd]
42. Zinc1587868
43. Urea, N-(2-hydroxyethyl)-
44. Akos001015414
45. Cs-w011301
46. As-10053
47. Sy038945
48. Ft-0686549
49. H0700
50. J-013628
51. Q27283827
52. F1019-0075
| Molecular Weight | 104.11 g/mol |
|---|---|
| Molecular Formula | C3H8N2O2 |
| XLogP3 | -1.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 104.058577502 g/mol |
| Monoisotopic Mass | 104.058577502 g/mol |
| Topological Polar Surface Area | 75.4 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 64 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
75
PharmaCompass offers a list of Urea, (2-Hydroxyethyl)- API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Urea, (2-Hydroxyethyl)- manufacturer or Urea, (2-Hydroxyethyl)- supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Urea, (2-Hydroxyethyl)- manufacturer or Urea, (2-Hydroxyethyl)- supplier.
PharmaCompass also assists you with knowing the Urea, (2-Hydroxyethyl)- API Price utilized in the formulation of products. Urea, (2-Hydroxyethyl)- API Price is not always fixed or binding as the Urea, (2-Hydroxyethyl)- Price is obtained through a variety of data sources. The Urea, (2-Hydroxyethyl)- Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 0639AB manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 0639AB, including repackagers and relabelers. The FDA regulates 0639AB manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 0639AB API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 0639AB supplier is an individual or a company that provides 0639AB active pharmaceutical ingredient (API) or 0639AB finished formulations upon request. The 0639AB suppliers may include 0639AB API manufacturers, exporters, distributors and traders.
0639AB Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 0639AB GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 0639AB GMP manufacturer or 0639AB GMP API supplier for your needs.
A 0639AB CoA (Certificate of Analysis) is a formal document that attests to 0639AB's compliance with 0639AB specifications and serves as a tool for batch-level quality control.
0639AB CoA mostly includes findings from lab analyses of a specific batch. For each 0639AB CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
0639AB may be tested according to a variety of international standards, such as European Pharmacopoeia (0639AB EP), 0639AB JP (Japanese Pharmacopeia) and the US Pharmacopoeia (0639AB USP).
